MX2020000142A - Sintesis de halicondrinas. - Google Patents

Sintesis de halicondrinas.

Info

Publication number
MX2020000142A
MX2020000142A MX2020000142A MX2020000142A MX2020000142A MX 2020000142 A MX2020000142 A MX 2020000142A MX 2020000142 A MX2020000142 A MX 2020000142A MX 2020000142 A MX2020000142 A MX 2020000142A MX 2020000142 A MX2020000142 A MX 2020000142A
Authority
MX
Mexico
Prior art keywords
synthesis
halichondrins
analogs
present
useful
Prior art date
Application number
MX2020000142A
Other languages
English (en)
Inventor
Isao Ohashi
Kentaro ISO
Takashi Fukuyama
Yoshito Kishi
Yanran Ai
Ning Ye
Qiaoyi Wang
Kenzo Yahata
Santhosh Reddy Naini
Shuji Yamashita
Jihoon Lee
Original Assignee
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College filed Critical Harvard College
Publication of MX2020000142A publication Critical patent/MX2020000142A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Furan Compounds (AREA)
  • Catalysts (AREA)

Abstract

La presente invencion proporciona metodos durante la sintesis de cetonas que involucra una reaccion de acoplamiento mediado por Ni/Zr; las reacciones de cetolizacion mediadas por Ni/Zr se pueden usar en la sintesis de halicondrinas (por ejemplo, halicondrina A, B, C; homohalicondrina A, B, C; norhalicondrina A, B, C) y analogos de las mismas; por lo tanto, la presente invencion tambien proporciona metodos sinteticos utiles para la sintesis de halicondrinas y sus analogos; tambien se proporcionan en el presente documento compuestos (es decir, intermedios) utiles en la sintesis de halicondrinas y analogos de los mismos; en particular, la presente invencion proporciona metodos y compuestos utiles en la sintesis del compuesto de formula (H3-A): (ver formula).
MX2020000142A 2017-07-06 2018-07-06 Sintesis de halicondrinas. MX2020000142A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762529333P 2017-07-06 2017-07-06
US201762529310P 2017-07-06 2017-07-06
PCT/US2018/041005 WO2019010363A1 (en) 2017-07-06 2018-07-06 HALICHONDRINES SYNTHESIS

Publications (1)

Publication Number Publication Date
MX2020000142A true MX2020000142A (es) 2020-07-22

Family

ID=63036376

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000142A MX2020000142A (es) 2017-07-06 2018-07-06 Sintesis de halicondrinas.

Country Status (14)

Country Link
US (2) US11548898B2 (es)
EP (2) EP3649135B1 (es)
JP (2) JP7370313B2 (es)
KR (2) KR102438417B1 (es)
CN (2) CN118515685A (es)
AU (2) AU2018297305B2 (es)
BR (1) BR112020000141A2 (es)
CA (2) CA3211559A1 (es)
ES (1) ES2940688T3 (es)
HU (1) HUE061306T2 (es)
IL (3) IL295588B2 (es)
MX (1) MX2020000142A (es)
SG (1) SG11201912342QA (es)
WO (1) WO2019010363A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
HUE060466T2 (hu) 2017-04-05 2023-03-28 Harvard College Makrociklusos vegyület és alkalmazása
IL295588B2 (en) 2017-07-06 2024-03-01 Harvard College Synthesis of the Lichondrins
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
JP7353281B2 (ja) 2017-11-15 2023-09-29 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびそれらの使用
CN111484393A (zh) * 2019-01-28 2020-08-04 上海茂晟康慧科技有限公司 一种顺,顺-3,5-二甲基-1-环己醇的制备方法

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61191687A (ja) 1985-02-20 1986-08-26 Fujisawa Pharmaceut Co Ltd ハリコンドリンb
US5436238A (en) 1992-03-12 1995-07-25 President And Fellows Of Harvard College Halichondrins and related compounds
US5338865A (en) 1992-03-12 1994-08-16 President And Fellows Of Harvard College Synthesis of halichondrin B and norhalichondrin B
GB9206244D0 (en) 1992-03-23 1992-05-06 Pharma Mar Sa Cytotoxic compound from a marine sponge
US5426194A (en) 1993-01-19 1995-06-20 Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 1
US5352804A (en) 1993-01-19 1994-10-04 Arizona Board Of Regents, A Body Corporate, Acting On Behalf Of Arizona State University Isolation and structure of Halistatin 2
JP2818381B2 (ja) 1994-01-18 1998-10-30 帝人株式会社 7−チアプロスタグランジン類およびその製造法
US6653341B1 (en) 1998-06-17 2003-11-25 Eisai Co., Ltd. Methods and compositions for use in treating cancer
JP4454151B2 (ja) 1998-06-17 2010-04-21 エーザイ・アール・アンド・ディー・マネジメント株式会社 大環状類似体及びそれらの使用並びに調製方法
US8097648B2 (en) 1998-06-17 2012-01-17 Eisai R&D Management Co., Ltd. Methods and compositions for use in treating cancer
JP2001305734A (ja) 2000-04-20 2001-11-02 Fuji Photo Film Co Ltd 光重合性組成物
JP2003261447A (ja) 2002-03-07 2003-09-16 Kyosei Seiyaku Kk 抗腫瘍剤
EP1771431A1 (en) 2004-06-03 2007-04-11 Eisai Co., Ltd. Intermediates for the preparation of halichondrin b
WO2006076100A2 (en) 2004-12-09 2006-07-20 Eisai Co. Ltd. Tubulin isotype screening in cancer therapy using halichondrin b analogs
JP2009184924A (ja) 2006-05-31 2009-08-20 Eisai R & D Management Co Ltd 生物学的試薬用化合物
KR101440201B1 (ko) 2007-03-07 2014-09-15 인터디지탈 테크날러지 코포레이션 MAC-ehs 프로토콜 데이터 유닛을 생성하고 프로세싱하기 위한 방법 및 장치
EP2069795A4 (en) 2007-06-18 2010-10-06 Medimmune Llc SYNERGISTIC TREATMENT OF EPHA2 AND ERBB2 EXPRESSIVE CELLS
BRPI0817909B1 (pt) 2007-10-03 2022-06-21 Eisai R&D Management Co., Ltd Métodos de obtenção e de preparação de uma composição diastereomericamente pura, compostos, e método para produzir os referidos compostos
MX2010005340A (es) 2007-11-16 2010-12-21 Eisai R&D Man Co Ltd Novedoso intermediario para la sintesis del analogo b de halicondrina y novedosa reaccion de desulfonilacion usada para el intermediario.
EP2274309B1 (en) 2008-04-04 2015-07-29 Eisai R&D Management Co., Ltd. Halichondrin b analogs
EP2528914B1 (en) 2010-01-26 2014-06-11 Eisai R&D Management Co., Ltd. Furo[3,2-b]pyrane derivatives useful in the synthesis of halichondrin b analogs
WO2012096926A2 (en) 2011-01-10 2012-07-19 President And Fellows Of Harvard College Method for delivering agents into cells using bacterial toxins
WO2012147900A1 (en) 2011-04-28 2012-11-01 Eisai R&D Management Co., Ltd. Microreactor process for halichondrin b analog synthesis
AU2012350420A1 (en) 2011-12-16 2014-07-10 Alphora Research Inc. Process for preparation of 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl) propanol derivatives and intermediates useful thereof
JP6300030B2 (ja) 2011-12-29 2018-03-28 サンド アクツィエンゲゼルシャフト 2−((2s,3s,4r,5r)−5−((s)−3−アミノ−2−ヒドロキシプロプ−1−イル)−4−メトキシ−3−(フェニルスルホニルメチル)テトラヒドロフラン−2−イル)アセトアルデヒド誘導体およびこれらを調製するためのプロセス
US9278979B2 (en) 2012-03-30 2016-03-08 Alphora Research Inc. Synthetic process for preparation of macrocyclic C1-keto analogs of halichondrin B and intermediates useful therein
US9650397B2 (en) 2013-05-15 2017-05-16 Alphora Research Inc. 3-((2S,5S)-4-methylene-5-(3-oxopropyl)tetrahydrofuran-2-yl)propanol derivatives, their preparation and intermediates useful thereof
CA2916537C (en) 2013-07-03 2021-07-27 Alphora Research Inc. Synthetic process for preparation of macrocyclic c1-keto analogs of halichondrin b and intermediates useful therein including intermediates containing -so2-(p-tolyl) groups
HUE049387T2 (hu) 2013-11-04 2020-09-28 Eisai R&D Man Co Ltd A halichondrin B analógjainak szintézisében hasznos makrociklizációs reakciók és köztitermékek
HUE043088T2 (hu) 2013-12-06 2019-08-28 Eisai R&D Man Co Ltd Halikondrin B analógok szintézisében alkalmazható eljárások
US10556910B2 (en) 2014-06-30 2020-02-11 President And Fellows Of Harvard College Synthesis of halichondrin analogs and uses thereof
WO2016038624A1 (en) 2014-09-09 2016-03-17 Cipla Limited "process for the preparation of macrocyclic ketone analogs of halichondrin b or pharmaceutically acceptable salts and intermediates thereof"
WO2016176560A1 (en) 2015-04-30 2016-11-03 President And Fellows Of Harvard College Chromium-mediated coupling and application to the synthesis of halichondrins
EP3292130B1 (en) * 2015-05-07 2020-09-30 Eisai R&D Management Co., Ltd. Macrocyclization reactions and intermediates and other fragments useful in the synthesis of halichondrin macrolides
MD3423105T2 (ro) 2016-03-02 2021-10-31 Eisai R&D Man Co Ltd Conjugați anticorp-medicament pe bază de eribulină și metode de utilizare
JP6978758B2 (ja) 2016-11-11 2021-12-08 プレジデント アンド フェローズ オブ ハーバード カレッジ パラジウム媒介ケトール化
KR20190138633A (ko) 2017-02-20 2019-12-13 폴리포 리미티드 암 치료용 약제학적 조합물
HUE060466T2 (hu) * 2017-04-05 2023-03-28 Harvard College Makrociklusos vegyület és alkalmazása
US9938288B1 (en) 2017-04-05 2018-04-10 President And Fellows Of Harvard College Macrocyclic compound and uses thereof
US11498892B2 (en) 2017-07-06 2022-11-15 President And Fellows Of Harvard College Fe/Cu-mediated ketone synthesis
WO2019009956A1 (en) 2017-07-06 2019-01-10 President And Fellows Of Harvard College SUMMARY OF MEDIUM MEDIATED KETONE
IL295588B2 (en) 2017-07-06 2024-03-01 Harvard College Synthesis of the Lichondrins
JP7353281B2 (ja) 2017-11-15 2023-09-29 プレジデント アンド フェローズ オブ ハーバード カレッジ 大環状化合物およびそれらの使用

Also Published As

Publication number Publication date
IL295588B1 (en) 2023-11-01
IL271660B (en) 2022-09-01
JP2023166381A (ja) 2023-11-21
CA3211559A1 (en) 2019-01-10
KR20200042464A (ko) 2020-04-23
IL295588B2 (en) 2024-03-01
AU2023203013A1 (en) 2023-06-01
CN111433211B (zh) 2024-05-07
US20230128195A1 (en) 2023-04-27
AU2018297305A1 (en) 2020-01-16
EP3649135B1 (en) 2022-12-28
BR112020000141A2 (pt) 2020-07-14
SG11201912342QA (en) 2020-01-30
EP4169924A3 (en) 2023-07-05
CA3069160A1 (en) 2019-01-10
EP3649135A1 (en) 2020-05-13
JP7370313B2 (ja) 2023-10-27
RU2020104842A (ru) 2021-08-06
US11548898B2 (en) 2023-01-10
KR20220124279A (ko) 2022-09-13
JP2020536046A (ja) 2020-12-10
AU2018297305B2 (en) 2023-02-16
HUE061306T2 (hu) 2023-06-28
WO2019010363A8 (en) 2019-06-06
CA3069160C (en) 2023-10-17
CN118515685A (zh) 2024-08-20
US20210230177A1 (en) 2021-07-29
IL271660A (en) 2020-02-27
IL295588A (en) 2022-10-01
WO2019010363A1 (en) 2019-01-10
IL307273A (en) 2023-11-01
KR102438417B1 (ko) 2022-09-01
ES2940688T3 (es) 2023-05-10
EP4169924A2 (en) 2023-04-26
CN111433211A (zh) 2020-07-17

Similar Documents

Publication Publication Date Title
MX2020000142A (es) Sintesis de halicondrinas.
MX2015002616A (es) Sintesis de bis(fluorosulfonil)imida.
MX350892B (es) Síntesis de compuesto antiviral.
NZ726356A (en) Processes for preparing antiviral compounds
CR20210032A (es) Compuestos
MX2020004504A (es) Derivados de fenoximetilo.
PH12015502031B1 (en) Tetrahydropyrrolothiazine compounds
UA122882C2 (uk) Синтез індазолів
JO3771B1 (ar) متوسطات لتحضير ساكوبيتريل وتحضيرها
NZ750265A (en) Methods for cross coupling
MX2023011454A (es) Reaccion de prins y compuestos utiles en la sintesis de macrolidos de halicondrina y analogos de los mismos.
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
MX2011011776A (es) Nuevos profarmacos de triptolite.
MX2021000348A (es) 2-fluoro-3-nitrotolueno cristalino y procedimiento para la preparacion del mismo.
SG10201805896SA (en) PPARγ AGONISTS FOR TREATMENT OF MULTIPLE SCLEROSIS
ZA202204803B (en) An efficient new process for synthesis of 2-amino-5-chloro-n-,3-dimethylbenzamide
MX2015017536A (es) Alquilacion con un alquil sulfonato de fluoroalquilo.
IN2013DE02956A (es)
MX2015013589A (es) Proceso e intermediario para la preparacion de pregabalina.
EA201200820A1 (ru) Способ синтеза промежуточных продуктов, применимых для получения замещенных индазолов и азаиндазолов
MX2017005988A (es) Compuestos intermediarios para la produccion de ingredientes perfumantes.
MY196769A (en) Synthesis of a thiosulfonic acid by a step of periodate mediated oxidative coupling of a thiosulfonic acid with an aniline
CU24289B1 (es) Nuevo procedimiento para la síntesis de la agomelatina
MX2020002703A (es) Proceso mejorado para la preparacion de trifloxistrobina.
EA201791098A1 (ru) Способ синтеза производных бензазепина